Kilitch Drugs (India) Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on March 13, 2026. Further, the company has informed the Exchange regarding voting results.
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kilitch Drugs (India) Limited held an Extraordinary General Meeting on March 13, 2026 at 11:30 AM via video conferencing, where shareholders voted on two resolutions. The first was an ordinary resolution to increase the company's authorized capital and amend the capital clause of the Memorandum of Association. The second was a special resolution to approve the issue of bonus shares. Both resolutions passed with overwhelming support, securing 100% of the valid votes cast in favour (12,396,194 shares out of 12,396,195), with only 1 vote against. Promoter and promoter group voted 100% in favour with 11,148,173 shares, while public non-institutions polled 1,247,822 votes with 99.9999% in favour. The scrutinizer was M/s. Deep Shukla & Associates, Practicing Company Secretaries.
The approval of bonus shares is a positive development for shareholders as it will increase the number of shares held, though the ex-bonus date and ratio are not specified in this filing. The authorized capital increase was likely a prerequisite to facilitate the bonus issuance, signalling management's confidence and a shareholder-friendly capital action.